These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6151044)

  • 1. Thalidomide in severe orogenital ulceration.
    Jenkins JS; Powell RJ; Allen BR; Littlewood SM; Maurice PD; Smith NJ
    Lancet; 1984 Dec; 2(8417-8418):1424-6. PubMed ID: 6151044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of thalidomide on orogenital ulceration.
    Bowers PW; Powell RJ
    Br Med J (Clin Res Ed); 1983 Sep; 287(6395):799-800. PubMed ID: 6412834
    [No Abstract]   [Full Text] [Related]  

  • 3. Thalidomide, orogenital ulcers, and risk of teratogenicity.
    Jenkins S; Powell RJ; Allen BR; Littlewood S; Maurice PD; Smith NJ
    Lancet; 1985 Mar; 1(8427):511. PubMed ID: 2857866
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy.
    Gardner-Medwin JM; Smith NJ; Powell RJ
    Ann Rheum Dis; 1994 Dec; 53(12):828-32. PubMed ID: 7864692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: a randomized double-blind trial.
    Davies UM; Palmer RG; Denman AM
    Br J Rheumatol; 1988 Aug; 27(4):300-2. PubMed ID: 3044474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of recurrent oro-genital ulceration with low doses of thalidomide.
    De Wazières B; Gil H; Vuitton DA; Dupond JL
    Clin Exp Rheumatol; 1999; 17(3):393. PubMed ID: 10410284
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of recurrent ulceration with low doses of thalidomide. Pilot study in 17 patients].
    de Wazières B; Gil H; Magy N; Berthier S; Vuitton DA; Dupond JL
    Rev Med Interne; 1999 Jul; 20(7):567-70. PubMed ID: 10434346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation and treatment of orogenital ulceration; studies on a possible mode of action of thalidomide.
    Powell RJ; Allen BR; Jenkins JS; Steele L; Hunneyball I; Maurice PD; Littlewood SM
    Br J Dermatol; 1985 Jul; 113 Suppl 28():141-4. PubMed ID: 4040386
    [No Abstract]   [Full Text] [Related]  

  • 9. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis.
    Revuz J; Guillaume JC; Janier M; Hans P; Marchand C; Souteyrand P; Bonnetblanc JM; Claudy A; Dallac S; Klene C
    Arch Dermatol; 1990 Jul; 126(7):923-7. PubMed ID: 2193629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pimecrolimus versus placebo in genital aphthous ulcers of Behcet's disease: a randomized double-blind controlled trial.
    Chams-Davatchi C; Barikbin B; Shahram F; Nadji A; Moghaddassi M; Yousefi M; Davatchi F
    Int J Rheum Dis; 2010 Aug; 13(3):253-8. PubMed ID: 20704623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.
    Jacobson JM; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Wu AW; Hooton TM; Sha BE; Shikuma CM; MacPhail LA; Simpson DM; Trapnell CB; Basgoz N
    J Infect Dis; 1999 Jul; 180(1):61-7. PubMed ID: 10353862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial.
    Hamuryudan V; Mat C; Saip S; Ozyazgan Y; Siva A; Yurdakul S; Zwingenberger K; Yazici H
    Ann Intern Med; 1998 Mar; 128(6):443-50. PubMed ID: 9499327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience.
    Cheng S; Murphy R
    Clin Exp Dermatol; 2012 Mar; 37(2):132-5. PubMed ID: 22007681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
    Jacobson JM; Greenspan JS; Spritzler J; Ketter N; Fahey JL; Jackson JB; Fox L; Chernoff M; Wu AW; MacPhail LA; Vasquez GJ; Wohl DA
    N Engl J Med; 1997 May; 336(21):1487-93. PubMed ID: 9154767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of thalidomide on the recurrence interval of continuous recurrent aphthous ulceration: A randomized controlled clinical trial.
    Zeng Q; Shi X; Yang J; Yang M; Zhao W; Zhao X; Shi J; Zhou H
    J Oral Pathol Med; 2020 Apr; 49(4):357-364. PubMed ID: 31514233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.
    Jacobson JM; Greenspan JS; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Pulvirenti JJ; Hooton TM; Shikuma C
    J Infect Dis; 2001 Jan; 183(2):343-346. PubMed ID: 11120935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide effective treatment for AIDS-related mouth ulcers.
    Randall P
    NIAID AIDS Agenda; 1995 Dec; ():2. PubMed ID: 11363350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide effective for oral ulcers.
    Posit Aware; 1996; 7(1):5. PubMed ID: 11363120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide, orogenital ulcers, and the risk of teratogenesis.
    Lehner T; Sullivan FM
    Lancet; 1985 Feb; 1(8423):288-9. PubMed ID: 2857357
    [No Abstract]   [Full Text] [Related]  

  • 20. Thalidomide: an alternative therapy for treatment of apthous ulcers (canker sores).
    Manesis DA
    STEP Perspect; 1995; 7(1):16-7. PubMed ID: 11362397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.